Follow the Beryl Drugs share price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Market capitalisation: €114.4m. The latest transaction was reported on 16 July 2026 (Acquisition). Among the most active insiders: Sudhir Sethi. All data is openly available.
8
Insider Decl.
n/a
Thresholds
€1,423
8 ops.
Buy Volume
n/a
n/a
Sell Volume
26Σ signal
Buys €1,423n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,380 of 27,439 companies
56.4
score / 100
Value
60
Quality
53
FCF yld-1.6%
Earn yld3.9%
EV/EBITDA5.5x
ROE4.4%
Gross mgn48%
Net mgn2.3%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.